Immune heterogeneity at diagnosis influences treatment response and survival in multiple myeloma.
Saved in:
| Title: | Immune heterogeneity at diagnosis influences treatment response and survival in multiple myeloma. |
|---|---|
| Authors: | Wang Y; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China., Lan T; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China., Gu S; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China., Zhang Y; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China., Liu P; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China. liu.peng@zs-hospital.sh.cn. |
| Source: | Discover oncology [Discov Oncol] 2026 Feb 06; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-04603-2 |
